Skip to main content

NeuroOne Medical Technologies Corporation

corporate_fare Company Profile

NeuroOne Medical Technologies Corporation

NMTC·NASDAQ·Industrial Applications And Services·CIK 0001500198

NEUROONE MEDICAL TECHNOLOGIES Corp is a medical technology company specializing in diagnostic, ablation, and deep brain stimulation technology for brain-related conditions like epilepsy and Parkinson's disease. The company also focuses on ablation and stimulation for pain management throughout the body, and drug delivery systems that include diagnostic and stimulation capabilities. NEUROONE MEDICAL TECHNOLOGIES Corp has received 510(k) clearance from the Food and Drug Administration (FDA) for four devices. These include the Evo cortical electrode technology, used for temporary (less than 30 days) recording, monitoring, and stimulation on the brain's surface, and the Evo sEEG electrode technology, for temporary (less than 30 days) recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Additionally, the company has clearance for its OneRF Brain Ablation System, which creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures, and the OneRF TN Ablation System, used for creating radiofrequency lesions for pain treatment or functional neurosurgical procedures. The company has a distribution agreement with Zimmer, Inc., granting Zimmer Biomet Holdings, Inc. a license to commercialize and distribute the Evo Cortical, Evo sEEG, and OneRF Brain Ablation System for brain applications. A limited market release of the OneRF TN Ablation System began in December 2025. Other products and indications are currently under development. The company's products include thin film electrode technology, such as cortical sheet and depth electrodes, which are vital for diagnosing neurological disorders like epilepsy, Parkinson's disease, dystonia, and essential tremors. The Evo Cortical portfolio includes various contact configurations of strip and grid electrodes.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for NMTC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-05, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for NMTC spans 10-Q, 8-K, 424B5, 10-Q/A.

Recent high-impact activity:

  • NeuroOne Posts 38% Q4 Revenue Growth, Lands Record $4.5M Order
  • NeuroOne's StereoCED Platform Hits Key Milestone in Robotic Drug Delivery
  • NeuroOne Q3: Revenue Up 16%, But Cash Drops to $2.0M and Going Concern Doubt Persists
  • NeuroOne Q3 Revenue Up 16% to $2.0M, Gross Margin Hits 59.9%; Cash Drops to $2.0M
  • NeuroOne Secures ISO 13485 Certification, Unlocking International Revenue Path

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$9.1M
Net Income
-$3.61M
Diluted EPS
-$0.09
Op. Cash Flow
-$2.84M
Free Cash Flow
-$2.92M
Gross Profit
$5.14M
Operating Income
-$4.23M
Cash & Equivalents
$6.57M
Debt / Equity
0.00×
Net Margin
-39.6%
Shares Outstanding
50.01M sh
Source: 10-K · filed 2026-01-23 · accession 0001213900-26-007245

Short Interest & Short Volume

2.39 days to cover

FINRA reported short interest of 207,063 shares in NMTC as of the October 30, 2026 settlement, a 0.1% decrease from the prior period — about 2.4 days to cover at its recent average daily volume. On November 19, 2026, 29.6% of NMTC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)207,063 shares as of October 30, 2026
Change vs prior period▼ 0.1%
Days to cover2.39 at avg daily volume of 86,817
Daily short volume (FINRA facilities)29.6% of 18,378 shares on November 19, 2026
5-day average short volume44.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for NMTC, detected from its recent SEC filings · based on capital-structure filings through 2026-06-12.

1 recent capital raiseATM program

Increased ATM Capacity · Significant Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with N →
$0.668 -1.02% today
52-week range · as of 2026-08-13 $0.668 – $6.96
Market cap
$6.08M
Volume
92.7K (1.4× avg)
3-mo avg 67.7K
Live data · 2026-11-20 20:04 UTC · Market open

show_chartPrice Chart

Loading chart...

feed NMTC - Latest Insights

NMTC
Oct 05, 2026, 9:17 AM EDT
Source: GlobeNewswire
Importance Score:
8
Updated Oct 5, 9:22 AM ET — NeuroOne reported preliminary Q4 FY2026 product revenue of $3.8 million, up 38.4% year-over-year, and full-year revenue of $10.5 million, a…
Price at Filing: $1.24
Real-time Price: $0.668 info
Change: -$0.572 (-46%) info
Market Cap: $6.076M info
NMTC
Aug 27, 2026, 9:10 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $2.22
Real-time Price: $0.668 info
Change: -$1.55 (-70%) info
Market Cap: $6.076M info
NMTC
Aug 13, 2026, 8:20 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.46
Real-time Price: $0.668 info
Change: -$0.792 (-54%) info
Market Cap: $6.076M info
NMTC
Aug 13, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $0.668 info
Change: -$0.982 (-60%) info
Market Cap: $6.076M info
NMTC
Aug 11, 2026, 8:35 AM EDT
Source: EQS
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $0.668 info
Change: -$0.892 (-57%) info
Market Cap: $6.076M info
NMTC
Jun 12, 2026, 4:45 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $3.24
Real-time Price: $0.668 info
Change: -$2.57 (-79%) info
Market Cap: $6.076M info
NMTC
Jun 12, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.24
Real-time Price: $0.668 info
Change: -$2.57 (-79%) info
Market Cap: $6.076M info
NMTC
Jun 12, 2026, 4:32 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $3.24
Real-time Price: $0.668 info
Change: -$2.57 (-79%) info
Market Cap: $6.076M info
NMTC
May 22, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.72
Real-time Price: $0.668 info
Change: -$3.05 (-82%) info
Market Cap: $6.076M info
NMTC
May 12, 2026, 8:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $0.668 info
Change: -$3.43 (-84%) info
Market Cap: $6.076M info
NMTC
May 12, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.668 info
Change: -$3.66 (-85%) info
Market Cap: $6.076M info
NMTC
May 04, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.44
Real-time Price: $0.668 info
Change: -$3.77 (-85%) info
Market Cap: $6.076M info
NMTC
Apr 30, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.80
Real-time Price: $0.668 info
Change: -$4.13 (-86%) info
Market Cap: $6.076M info
NMTC
Apr 14, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8058
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Apr 03, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.795
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Mar 26, 2026, 8:35 AM EDT
Source: EQS
Importance Score:
8
Price at Filing: $0.748
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Mar 09, 2026, 8:00 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.8998
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Mar 03, 2026, 8:49 AM EST
Filing Type: 4
Importance Score:
9
Price at Filing: $0.670
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Feb 27, 2026, 4:31 PM EST
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.6704
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
NMTC
Feb 17, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.730
Real-time Price: $0.668 info
Change: Reverse Stock Split info
Market Cap: $6.076M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets